Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
about
Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.Statins in patients with chronic kidney disease: why, who and when?Twenty four-hour ambulatory blood pressure monitoring and lipid levels before, 3, 6 and 12 months after the onset of hemodialysis in chronic kidney disease patients: a pilot study.Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis.
P2860
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@en
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@nl
type
label
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@en
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@nl
prefLabel
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@en
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@nl
P1476
Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering.
@en
P2093
Kosmas I Paraskevas
P304
P356
10.1007/S11255-007-9307-6
P577
2007-12-08T00:00:00Z